Controlled Trial of Dipyridamole in Cerebral Vascular Disease

Joan Acheson, G Danta, E. C. Hutchinson

BMJ · 1969 · 186 citations · 14 references

DOIFull text

Open access

Concepts

Abstract

A controlled double-blind study of the effect of dipyridamole was performed in 169 patients with established cerebral vascular disease. A dose of 400 mg. was used initially, given daily for an average of 14 months; the dose was then increased to 800 mg. daily for a further average period of 11 months. When the incidence of cerebral ischaemic episodes during treatment was compared in the drug-treated and placebo-treated groups no significant difference was found.

References

14